Hillary Clinton accuses Canadian drugmaker Valeant of 'predatory pricing'

Hillary Clinton has stepped up her battle against predatory drug pricing in her bid to become the next U.S. president -- and she is setting her sights on Valeant Pharmaceuticals.

See Full Article

In a new campaign ad on her YouTube page, the front-runner for the Democratic presidential nomination vows to go after the Quebec-based drugmaker.

Valeant has been accused of gouging patients on drug costs -- allegations it has denied.

The ad posted Monday cites the case of a woman who has been taking a brand name medication since the 1980s that, at one time, it says cost about $180 for 10 shots.

The name of the medication is not disclosed in the ad, which appears to have been filmed at a town hall-type campaign stop in January.

The ad shows Clinton waving a letter and saying the cost of the woman's latest refill has shot up to $14,700 for the same 10 vials.

"The company is called Valeant Pharmaceuticals. I am going after them," Clinton tells the meeting to a round of applause.

"This is predatory pricing and we're going to make sure it is stopped."

Valeant said after it became aware of the patient's story in January, it contacted her to determine whether it could help cover the costs of the medication as part of a patient assistance program.

"She informed us that her insurance provider covers the drug, so it is not a significant out-of-pocket expenditure for her," Valeant said in a statement Tuesday.

Valeant also said there has been a generic version of the drug available since 2003 and that its share of the overall market for the medication has declined to less than one per cent.

"Whenever the sales volume of a drug declines, manufacturers must consider pricing adjustments to keep production of the drug viable," Valeant said. "Patients are able to choose generic versions of the drug, however, at significantly lower prices."

The company, one of several companies under investigation as the U.S. Congress looks at price increases for certain specialty drugs, has seen its share price plummet to well under $100 from above $346 last summer. On Tuesday, the stock fell $6.55 to settle at $87.94 on the Toronto Stock Exchange.



Advertisements

Latest Economic News

  • Toronto Millennials dream of backyards but are stuck in condos: report

    Economic CTV News
    Toronto Millennials are the most educated group in Canada, but high housing costs are keeping some of the country’s most qualified workers in their parents’ basements or pushing them out of the province altogether, a new report suggests. Source
  • Facebook's Mark Zuckerberg apologizes to EU lawmakers over data leak

    Economic CBC News
    Facebook boss Mark Zuckerberg apologized to European Union lawmakers on Tuesday for a massive data leak, in his latest attempt to draw a line under a scandal that has rocked the world's biggest social media network. Source
  • What your kids should know about money in kindergarten, grade school and high school

    Economic CTV News
    Too many Canadians are reaching adulthood without the skills to successfully manage their financial futures, according to personal finance coach David Lester. The best way he sees to build that knowledge is for parents to start schooling their kids about money as early as possible. Source
  • The New York Stock Exchange just named its first female president in its 226-year history

    Economic CBC News
    The New York Stock Exchange for the first time in its 226-year history will be led by a woman. Stacey Cunningham, who started her career as a floor clerk on the NYSE trading floor, will become the 67th president of the Big Board. Source
  • New York Stock Exchange just named the 1st female president in its 226-year history

    Economic CBC News
    The New York Stock Exchange for the first time in its 226-year history will be led by a woman. Stacey Cunningham, who started her career as a floor clerk on the NYSE trading floor, will become the 67th president of the Big Board. Source
  • Ex-Valeant, Philidor executives convicted of kickback scheme

    Economic CBC News
    A former Valeant Pharmaceuticals International Inc executive and the former chief of mail order pharmacy Philidor Rx Services were found guilty on Tuesday of defrauding Valeant through a multimillion-dollar kickback scheme. The verdict, handed up by a jury in Manhattan federal court, comes on the heels of Valeant's announcement that it will change its name to Bausch Health Companies Inc as it seeks to distance itself from a series of scandals under its previous management. Source
  • Women cite 'grass ceiling' in male-dominated weed industry

    Economic CTV News
    JUNEAU, Alaska -- When Danielle Schumacher attended her first convention of marijuana activists about 15 years ago, she could count on one hand all the women in a room of older men. The lack of diversity struck the then-college student, who remembers feeling out of place but also determined to make her mark. Source
  • Airlines caving to Beijing despite White House protest

    Economic CTV News
    SHANGHAI -- Global airlines are obeying Beijing's demands to refer to Taiwan explicitly as a part of China, despite the White House's call this month to stand firm against such "Orwellian nonsense." The Associated Press found 20 carriers, including Air Canada, British Airways and Lufthansa, that now refer to Taiwan, the self-ruled island that Beijing considers Chinese territory, as a part of China on their global websites. Source
  • McDonald's workers in U.S. file sex harassment claims

    Economic CTV News
    NEW YORK -- Energized by the #MeToo movement, two national advocacy groups are teaming up to lodge sexual harassment complaints against McDonald's on behalf of 10 women who have worked at the fast food restaurant in nine cities. Source
  • OREA isn't backing down from GTHA affordability messaging after TREB controversy

    Economic CTV News
    TORONTO -- The Ontario Real Estate Association isn't backing away from its campaign on the lack of housing affordability in Toronto, even after harsh criticism from the province's largest real estate board. On Tuesday, OREA executives unveiled a Ryerson University report, which it sponsored, that found millennials in the Greater Toronto and Hamilton area are living with their parents longer as they struggle to find affordable houses in a market with limited supply. Source